## 

## 

## 

## 

|Contents|Contents|||||Pa|
|---|---|---|---|---|---|---|
|Chair's Report 2021-22|||||||
|Trustees'<br>Annual<br>Report 2021-22|||||||
|(including<br>Directors' Report and Strategic|||Reportj||||
|Our vision ofcare||||||3|
|Services and activities|in the year|||||4|
|Financial overview||||||7|
|Fundraising||||||10|
|Structure, governance|and management|||||14|
|Legal and administration||||||19|
|Independent<br>Auditor's|Report|||||25|
|Statement ofFinancial|Activities|(Including|Income and|Expenditure|Account)|29|
|Balance Sheets||||||31|
|Statement ofCash Flows||||||32|
|Notes tothe Financial Statements||||||33|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

|General||~|Over 3196of our patients<br>have a non-cancer<br>diagnosis||
|---|---|---|---|---|
|||~|1,758patients were cared for by clinical teams||
|Community|team||In the year our teams made 6,289visits to patients at home and in||
||||care homes across Sheffield,<br>and 11,838 phone<br>and video|calls to|
||||them<br>in support oftheir care||
||||St Luke's received 2,393referral requests to our community|service|
||||from GPs and other healthcare<br>professionals,<br>a 1096increase on the||
||||prior year||
||||33%of visits were to patients<br>who required<br>urgent care from our||
||||Intensive Treatment<br>Team||
||||St Luke's continues to provide specialist nutritional<br>and individually||
||||designed food and drink packages to around 15community|patients|
||||each week, free ofchar e||
|In Patient Centre (IPC)|||24 hour care and support<br>by our team ofspecialist<br>nursing,|medical|
||||and health professional<br>staff||
||||Over the last 12months,<br>we cared for 316patients at our IPC (302||
||||admissions)||
||||During the year, we provided 4,934days ofcare on the IPC||
||||On average,<br>each patient<br>stayed at the IPC for 16 days with 3296||
||||able to return home after specialist intervention<br>treatment||
|Bereavement|Support team|~|570 relatives<br>were supported<br>with bereavement<br>counselling<br>and||
||||supported<br>after the death ofa loved one||
|||~|The Bereavement<br>team of staff and volunteers<br>delivered|2,764|
||||sessions with clients<br>in the year||



## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 


|Asset Class|Ranges|Comparative<br>Indices||||
|---|---|---|---|---|---|
|||7.5% BofA Merrill<br>Lynch Gilt 5-15Years||||
|Fixed Interest|10 - 35|7.5% BofA Merrill<br>Lynch<br>E|Corp and Collateralized|Index|5% BofA Merrill|
|||Lynch Inflation<br>Linked Gilt|1-10|||
|Equities|45-75|30%MSCI United<br>Kingdom|Equity IMI (Net)|||
|||30% MSCI ACWI World Index Ex UK (Net)||||
|Property|0 —12.5|MSCI UK IMI Liquid Real Estate (Net)||||
|Other Assets|2.5-20|IWI Alternatives<br>Composite||||
|Cash|0-20|||||





## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

|Name|||Role|||Length of Service at|Length of Service at|Qualifications||Governance|Support|
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||St Luke' s/in|role|||Lead||
|Peter Hartland|||Chief Executive Officer|||14years, 12|years|BSc(Hons), ACA-||Board ofTrustees;||
|||||||in role||Associate ofThe||Nominations|and|
|||||||||Institute of Chartered||Remuneration||
|||||||||Accountants<br>in||Committee||
|||||||||England<br>and Wales||||
|Kathryn|Burkitt||Director|of Income,||13years, 5years in||BA(Hons), MlnstF||SDe Planning||
||||Media and Marketing|||role||||Committee||
|Io Lenton|||Director|of Care|and|13years, 3years in||Registered<br>Nurse,|BA|Healthcare||
||||Lead for Healthcare|||role||(Hons) Supportive|&|Governance||
||||Partnerships|||||Palliative Care||Committee||
|Tony Saunders|||Director|of Finance and||12years, 7years in||BA(Hons)||Resource and||
||||Chief Operating||Officer|role||FCA —Fellow ofThe||Finance Committee;||
|||||||||Institute ofChartered||Audit and Risk||
|||||||||Accountants<br>in||Committee||
|||||||||En land and Wales||||
|Sam|||Medical|Director and||9years' service and||MBChB, MRCP, Dip,||Research||
|Kyeremateng||(1)|Clinical Lead for|||in role||PallMed||Committee||
||||Programme|||||||||
||||Develo|ment||||||||





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 



## 

## 

|Board|ofTrustees|Neil MacDonald|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|||Chair ofthe Board ofTrustees. Exofficio member||of:the Audit|||and Risk||Committee,|the|
|||Resource and Finance Committee, the Nominations|||and|Remuneration|||Committee,|the|
|||Healthcare<br>Governance<br>Committee,<br>and the Research Committee|||||||||
|||Dr Lucy Cormack|||||||||
|||Member ofthe Healthcare|Governance<br>Committee||and the Audit and|||Risk Committee|||
|||Louise Edwards-Holland|||||||||
|||Member<br>of the<br>Resource<br>and<br>Finance<br>Committee||||and|the|Nominations||and|
|||Remuneration<br>Committee|||||||||
|||Laurence Gavin|||||||||
|||Member ofthe Resource and Finance Committee|||||||||
|||Professor Diana Greenfield|||||||||
|||Member ofthe Healthcare|Governance<br>Committee||and|the Research||Committee|||
|||Louisa Harrison-Walker|||||||||
|||Member ofthe Resource and Finance Committee|||||||||
|||Susan inglis|||||||||
|||Chair ofthe Healthcare<br>Governance<br>Committee||and member|||ofthe|Nominations||and|
|||Remuneration<br>Committee|and the Audit and Risk|Committee|||||||
|||Martin McKervey|||||||||
|||Member ofthe Resource and Finance Committee|||||||||
|||Amy Stanbridge|||||||||
|||Chair ofthe Audit and Risk|Committee||||||||
|||DrToni Schwarz|||||||||
|||Member ofthe Healthcare|Governance<br>Committee||and|the Research||Committee|||
|||Andrew<br>Snelling|||||||||
|||Chair ofthe Resource and|Finance Committee<br>and||Honorary||Treasurer;||member ofthe||
|||Nominations<br>and Remuneration<br>Committee|||||||||
|||Professor Sarah Thomas|||||||||
|||Chair ofthe Nominations<br>and Remuneration<br>Committee||||and|member|ofthe Healthcare|||
|||Governance<br>Committee|||||||||
|||Dr Mark Durling (appointed|28September 2021)||||||||
|||Member ofthe Healthcare|Governance<br>Committee||||||||
|||Shelley Garlington<br>(appointed<br>28September 2021)|||||||||
|||Member ofthe Resource and Finance Committee|||||||||





## 

## 

## 

## 

## 

## 



## 

|Bankers|Svenska Handelsbanken|AB (publ)|
|---|---|---|
||Seventh<br>Floor||
||3St Paul's Place||
||129Norfolk Street||
||Sheffield 512IE||
||National<br>Westminster|Bank Pic|
||997Abbeydale<br>Road||
||Sheffield S72QE||
|Solicitors|Knights pic||
||Commercial<br>House||
||14Commercial<br>Street||
||Sheffield S12AT||
||Freeths||
||Fifth Floor||
||3St Paul's Place||
||129Norfolk Street||
||Sheffield S12JE||





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



|||||000<br>H<br>00|000<br>H<br>00|W|O<br>I<br>I nl 0<br>Nl u<br>Olmmm<br>I la<br>ID<br>CI IO<br>0 ID»alai<br>orttDoonl<br>lut<br>ftl|O<br>I<br>I nl 0<br>Nl u<br>Olmmm<br>I la<br>ID<br>CI IO<br>0 ID»alai<br>orttDoonl<br>lut<br>ftl|O<br>I<br>I nl 0<br>Nl u<br>Olmmm<br>I la<br>ID<br>CI IO<br>0 ID»alai<br>orttDoonl<br>lut<br>ftl|O<br>I<br>I nl 0<br>Nl u<br>Olmmm<br>I la<br>ID<br>CI IO<br>0 ID»alai<br>orttDoonl<br>lut<br>ftl||||||D I<br>co 00 00<br>lo d<br>ID<br>O<br>IHUI|D I<br>co 00 00<br>lo d<br>ID<br>O<br>IHUI|Ol<br>m<br>ID|||ol<br>cn I<br>N' 00' m' 0' <br>H H<br>I Ol<br>Nl N '0|ol<br>cn I<br>N' 00' m' 0' <br>H H<br>I Ol<br>Nl N '0|N'|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||'0 H<br>D||W|rco|||||||||00<br>ID|'u<br>I|r||||||
|||||4I 0|||to|||||||||00|0|N<br>Ol||||||
|||||l! H<br>0 N0||W||||||||||||||||||
|||||000 D0<br>O0||||||||||||||||||||
|||||'0<br>00<br>N<br>tU 0||W|m0<br>Ca<br>Ca|aoo<br>mm<br>d<br>I 0<br>I H<br>0<br>I N<br>I co N<br>d m ui ui 00 <br>DnodmmN<br>N<br>U! 0 N<br>H<br>N||I<br> r||I<br>Ct ul0<br>r 0<br>r||||0<br>co co<br>Ul<br>la<br>m H||Iu<br>mco|||ol In I<br>I<br>r cndmoo<br>r »mom<br>H co m 0 «i<br>m<br>cn<br>m N<br>0|||
|||||0|||m|||||||||||O||||||
|||||I <br>'0 N<br>C 0<br>N<br>E||ul||Ol <br>mm|H<br>H<br>Ol 0I<br>Nt<br>ruomo|||Ol<br>ICI <br>0||Ol<br> ul<br>Ul<br>4\0<br> H|0 NI<br>H H Ciat<br>In H d<br>Co<br>Nt|||VI<br>r|||~I<br>CO lo le<br>D<br>N 8 m 8 Icl<br>romcid<br>lo<br>0 ND<br>m N H N|||
|||||I||||||||||||||m|||I«|||
|||||0!H<br>II N<br>N<br>ll<br>Io<br>C<br>IL'||ul|H<br>Ol<br>m<br>lo||||||||0<br>D<br>Ol||IO<br>Nl<br>Ol<br>Ca|||||||
|||||'0 H<br>4I N0<br>e<br>CC<br>00000<br>4I0|W|||||||||||||||||||
||III|||||||||||||||||||||||
||Dl<br>I<br>IIJ<br>~E|0||ll N<br>4I<br>C4<br>t<br>1!<br>CI<br>0|W|||d<br>In H H<br>Ol In<br>ln<br>Co<br>Ul<br>Nl<br>Cl In <br>Ol Cl<br>Cr N<br>Ca<br>ID<br>I«NOON<br>d el I»<br>Ul<br>lu||Nl<br> g||Ol<br>CO <br>O||Ol<br> lo<br>ul<br>la0||Ul 0<br>D N<br>0 al|r<br>Iu||||0 co cc co <br>NINH<br>I<br>N|4l||
||IJ <br>Z|0<br>u||||||||||||||||||||||
||~C<br>Z|CE||Cl0|||||||||||||||||m m<br>rn m|m||
||IL|I<br> v||||||||||||||||||||||
|IllIJ<br>tu<br>C/I0z<br>vr<br>ia<br>IC0<br>Iill|Id<br>0 cd<br>Z 0<br>CD<br>IZ Id<br>X lz Z<br>ill<br>IJ<br>I- D<br>0<br>CE<br>0<br>0 C~<br>0 IO<br>~~00<br>9 ooo<br>0 Z<br>0 D CI<br>0 cf<br>I<br>IE<br>0 0 III<br>8|||||E <br>0<br>Cl<br>E <br>C|0<br>00<br> D<br>Ia<br>4I<br> 'v<br> 0<br>E<br>0!<br>0<br>0<br>tol!<br>C<br>t!me o<br>C 0<br>en 0<br>Ct<br>O o.rV<br>0||Io<br>~I<br>4I<br>E c<br>0 0<br>c 0<br>tU<br>E<br>4<br>E E<br>0r<br>0 VI<br>4I<br>E<br>0<br>E<br>0||t t<br>e<br>a c<br>C V<br>IOD<br>r u<br>V V||00D<br>0V<br>00<br>la<br>I<br>P<br>CI0<br>0<br>0<br>V<br>0 '0<br>0<br>0<br>E<br>0 Ol 0<br>ll 0 N<br>a&z<br>—z<br>0 0<br>VI V<br>tal0<br>'tl0<br>O<br>00<br>50 0<br>u<br>e<br>I<br>le<br>r<br>CI<br>ot<br>0 0 0||||||00<br>Cla4<br>D 0<br>C<br>4I<br>x 0<br>lu<br>OC||0<br>0o<br>D<br>00'0llC<br>0<br>lo<br>Ol<br>V0<br>OD<br>Cl<br>N<br>4I<br>0<br>0<br>tu<br>E<br>CC<br>Cl<br>X<br>00<br>CI<br>cr<br>Ro E<br>0<br>= ~t<br>e00<br>V|||





|||0 <br>0|0<br>N|UI||I<br>I O<br>I<br>Ut<br>mc,<br>r<br>Ul O N<br>Ul<br>I<br>ID N<br>UC<br>io lo m 8<br>o<br>IOl<br>r|I<br>I O<br>I<br>Ut<br>mc,<br>r<br>Ul O N<br>Ul<br>I<br>ID N<br>UC<br>io lo m 8<br>o<br>IOl<br>r|I<br>I O<br>I<br>Ut<br>mc,<br>r<br>Ul O N<br>Ul<br>I<br>ID N<br>UC<br>io lo m 8<br>o<br>IOl<br>r|I<br>I O<br>I<br>Ut<br>mc,<br>r<br>Ul O N<br>Ul<br>I<br>ID N<br>UC<br>io lo m 8<br>o<br>IOl<br>r||||||'U<br>Ul<br>m||CD<br>m<br>CtD|CD<br>m<br>CtD|N|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||'0 <br>g <br>0|N<br> o<br>D|W||m<br>'<br>lh<br>Olm<br>Ul<br>Ol<br>Ol<br>O|||Ol|0o<br>C<br>Ct|||||00<br>00|0<br>00||||||
|||'0 <br>0 <br>0<br>44 <br>00|N<br> N0<br>N<br>D0|Ul|||N<br>'<br>I<br>m<br>Cl<br>I<br>ID<br>r||ID<br>I<br>m|lh<br>Ih<br>m||||||ID<br>I<br>m<br>r|||CCl<br>C|o000<br>m|00oo0|
|||'ll<br>0 <br>0<br>0|N<br> N0<br>N<br>C|Ut|||0<br>CC<br>cc m 0<br>r<br>m cc<br>I<br>I<br>I<br>N<br>ID<br>Dt <br>CC<br>Ul 0 <br>m|A<br>I<br> 0<br> 0<br>m|o<br>I<br>m|o0||0<br>m<br>mo <br>Ut|lh<br>I<br> r<br> O|5<br>~4|0<br>0|ID<br>m<br>0||A<br>CC<br>m<br>0|||o<br>ID|
|||'0<br>0 <br>00|IU<br>IU<br> o<br>N|Ul|||ID Ol N N<br>~<br>Ul<br>IO<br>Ol 0<br>tU<br>Ul<br>ID<br>CC hl<br>I<br>IONUIIO<br>r odom<br>0 Ul<br>cl<br>r4||00|Cl<br>IA||m<br>r <br>N|m<br> 0<br>r<br> 0|IO|I<br>CO<br>lhm'|||ID||ID<br>CD<br>ID<br>OI<br>Ct<br>m|Ol<br>Ul<br>Ul<br>CC<br>IU<br>Ul|
|||'0|N|UI|||||o|||||||||||||
|||8|N|||||||||||||||||||
|||0|C|||||||||||||||||||
|||rc||||||||||||||||||||
|||4I <br>0W|N0<br>N|W|||Ul<br>Ul<br>Ol<br>lh<br>IO<br>t||Ol<br>Ih|Ol<br>III|||||4|lh|||8<br>8|0<br>Ct000<br>Ih|o0o<br>Ct|
|||4t <br>CI|C<br> 0|||||||||||||||||||
|VI<br>IU<br>I<br>IIJ|||N<br>N<br>N0<br>D0|W|||Wo All<br>d 0 N<br>rU<br>m<br>Ul<br>ID<br>Ul<br>Ol<br>ID N<br>Ol<br>0 0 0 0 <br>4 N N<br>Ul|IA<br>IO<br> IA<br>Ch|cr|||m<br>I|UI<br> 0||0<br>Ut|0<br>m||8|CC<br>m|o0o|Ol<br>Irl<br>Ul<br>CC<br>IA<br>m|
|~E||||||||||||||||||||||
||C|||||||||||||||||||||
||0|||||||||||||||||||||
||UE||Cl0||||mmmmm|||||||||||||||
||or|||||||||||||||||||||
|IL|v|||||||||||||||||||||
|C Id<br>z ~o<br>IU UId<br>2<br>UI Z<br>IUI- g L'<br>CE 0<br>CE<br>VI 02<br>0 E~<br>9 0<br>NI<br>~~00<br>0<br>DOER<br>E z<br>0<br>VIZ uc(<br>0 c 5<br>IJ|||||0<br>IC<br>D <br>00 <br>0. <br>U|,IO<br>CI<br>IC<br> 0<br> '0<br> 0<br> 0|E0<br>0<br>IC<br>0<br>CI<br>0<br>4I<br>85<br>~I<br>Cl0<br>Cl<br>IC<br>4<br>C<br>Ct<br>C0<br>E<br>E0<br>00C. 0<br>44<br>40<br>~I|O0<br>Cl<br>C0<br>4I<br>4<br>CI<br>D 0||IC<br>E000<br>4IR|0 <br>0<br>0 <br>0 <br>0|D<br>CI<br> '=<br> 0|D<br>Cl<br>4I<br>C||0<br>ClZ|I<br>4II<br>Cl<br>c E 00<br>0<br>c D 0<br>0 0<br>tl<br>ll<br>Cl<br>0<br>D<br>4I<br>N59|||C<br>C<br>C<br>4t<br>4I<br>U|ID<br>0|NN0<br>N<br>v<br>4<br>I<br>0<br>C<br>0|





## 

## 

## 

|||||||||GROUP||CHARITY|
|---|---|---|---|---|---|---|---|---|---|---|
||||||||2022|2021|2022|2021|
||||||Note||f|6|f|f|
|Fixed assets|||||||||||
|Tangible assets|||||7||6,751,386|6,728,023|6,751,386|6,728,023|
|Investments|||||8||4,671,740|2,590,952|4,671,814|2,591,026|
||||||||11,423,126|9,318,975|11,423,200|9,319,049|
|Current assets|||||||||||
|Stock —goods for|resale||||||67,495|152,140|67,495|152,140|
|Debtors|||||9||3,501,098|2,216,924|3,571,708|2,264,127|
|Cash at bank and|in|hand|||10||3,411,519|2,734,663|3,329+16|2,665,946|
||||||||6,980,112|5,103,727|6,968,219|5,082,213|
|Creditors: amounts||falling due|within one year||11||(3224 292)|(2815208)|(3224 292)|(2801125)|
|Net current assets|||||||3,755,820|2,288,519|3,743,927|2,281,088|
|Total assets less current liabilities|||||||15,178,946|11,607,494|15,167,127|11,600,137|
|Creditors: amounts||falling due|after more than||12||(50,387)|(98,808)|(50,387)|(98,808)|
|one year|||||||||||
|Net assets|||||19||15,128,559|21,50fs686|15,116,740|11,501,329|
|Charity Funds|||||||||||
|Generalfunds|||||15||13,328,559|10,008,686|13,316,740|10,001,329|
|Designated<br>funds|||||15||1,800,000|1,500,000|1,800,000|1,500,000|
|Total unrestricted|funds-||||||||||
|Including<br>investments||revaluation||reserve|||||||
|(E158,767(2021:f124,959))|||||15||15,128,559|11,508,686|15,116,740|11,501,329|
|Restricted|||||16||||||
|Total Charity funds|||||||25.228359|11,5D8,686|15,116,740|11,501,329|
|The charity has taken advantage<br>of <br>own statement<br>offinancial activities||||the exemption<br>in the financial|allowed<br>under section 408ofthe Companies<br> statements.<br>The surplus ofthe charity<br>isf3||||Act 2006 and has not presented<br>its<br>615411(2021:f2 548 542).||





## 

## 

## 

||||||2022||2021|
|---|---|---|---|---|---|---|---|
||||Note|||||
|Cash flows from operating|activities:|||||||
|Net cash flow provided<br>by operating<br>activities|||17||2,829,278||3,180,933|
|Cash flows from Investing|activities|||||||
|Interest received||||313||1,511||
|Dividends<br>received<br>Purchase oftangible fixed|assets|||49,190<br>(202,180)||25,760<br>(199,602)||
|Proceeds from sale offixed assets||||250||198,004||
|Purchase of investments<br>Proceeds from sale ofinvestments||||(2,777,496)<br>484,385||(1,085,529)<br>713,918||
|Net cash flow from investing<br>activities|||||(2,445,538)||(345,938)|
|Increase in cash and cash <br>the year|equivalents|in|||383,740||2,834,995|
|Cash and cash equivalents<br>2021|as at 1April||18||3,785,219||950,224|
|Cash and cash equivalents<br>2022|as at31March||18||4,168,959||3,785,219|





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

|2.|Income from investments|Income from investments||||||
|---|---|---|---|---|---|---|---|
|||||||2022<br>f|2021f|
||Dividends<br>and interest|||||49,190|25,760|
||Bankinterest|||||313|1,511|
|||||||49,503|27,271|
||Income from investments||in both years is unrestricted.|||||
|3.|Analysis ofexpenditure|||||||
|||||Direct costs|Support|Total|Tota<br>I|
||||||costs|2022f|2021<br>f|
||Raising funds|||||||
||Legacies and donations|||275,988|91,266|367,254|311,772|
||Special events and sundry||sales|178,581|61,867|240,448|218,499|
||Charity shops|||2,053,530|67,788|2,121,318|1,633,949|
||Lottery pdzes and expenses|||237p436|42,572|280,008|290,057|
||Investment<br>management||costs|16,896||16,896|6,384|
|||||2,762,431|263,493|3,025,924|2,460,661|
||Charitable<br>activities|||||||
||Inpatient<br>care|||3,842,197|635,059|4,477,256|4,365,312|
||Medicine and drugs|||106,569||106,569|82,852|
||Early support for terminal||illness|134,265|7,366|141,631|156,709|
||Integrated<br>community|care services||1,634,528|371,274|2,005,802|2,402,711|
||Education<br>and training|||266,994|69323|336,317|306,725|
|||||5,984,553|1,083,022|7,067,575|7,314,309|
||Total|||8,746,984|1,346,515|10,093,499|9,774,970|
||2021Total|||8,390,062|1,384,908|9,774,970||





## 

## 

|Governance|costs|||||||
|---|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Tota|I|
||||funds|funds|2022|2021||
||||f|f||f||
|Strategic management|||81,216||81,216|84,219||
|Legal, professional||and support costs|16,883||16,883|16,522||
||||98,099||98,099|100,741||
|2021Total|||100,141||100,741|||
|Employment|costs|||||||
||||||2022|2021||
||||||f|f||
|Staff costs||||||||
|Wages and|salaries||||5,658,503|5,707,213||
|Social security costs|||||503,840|484,853||
|Pension costs|||||298,907<br>6, 6,160|304,849<br>6, 969 6||



|he emoluments<br>ofemployees<br>who earned overf6|0000 during the year were within the|following<br>ranges:|
|---|---|---|
||Number|ofemployees|
||2022|2021|
|E100,000-E110,000|1|0|
|f90,000-f100,000<br>f80,000-E90,000|0<br>1|1<br>0|
|E70,000-E80,000|1|2|





## 

## 

## 

## 

|||Head count - Average|Head count - Average|
|---|---|---|---|
|||Number ofemployees||
|||2022|2021|
||||as restated|
|Ancillary|||42|
|Medical and|nursing||66|
|Allied Health|Professional||31|
|Professional|and technical||27|
|Fundraising|||10|
|Administration|||15|
|Shops|||45|
|||240|236|



## 

|||||2022|2021|
|---|---|---|---|---|---|
|||||E|E|
|Auditor's<br>remuneration;||||||
|Audit||||20,073|14,800|
|Other Services||||1,628|1,200|
|Hire ofother|assets —operating||leases|265,348|238,538|
|Loss/(profit)|on disposal of|fixed|assets|1,286|(3,000)|
|Impairment|on revaluation|offixed assets||61p991|603,843|
|Depreciation||||115,286|134,289|





|||||||||||||||||||||||Cl|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||||||||||||0|
|||||||||||||||||||||||IO|
|||||||||||||||||||||||IO|
|||||||||||||||||||||||O!|
|||||||||||||||||||||||U|
|||||||||||||||||||||||IO|
||||CI00I-|||||N <br>M<br>N <br>Ol|O<br>Ol<br>I <br> 0<br> M|N|||||Ul<br>N<br>OO 0<br>lo<br>I 8<br>I<br>I<br>mmm<br>M|||~I|||fU0,<br>IO|Cl<br>Cl<br>N0 IO<br>C0!|
|||||||||||||||||||||||IO<br>N<br>Cl|
|||||||||||||||||||||||0Q.|
||O<br>0e <br>EL <br>0<br>Ol||Cl<br> .U<br> S<br>SE||||N <br>Ul <br>O<br>lO||0<br> m <br>IO<br>tO|8|||M||Ol<br>IO|0||||lO<br>IO|M<br>m<br>m|I<br>CO 0<br>C<br>OI<br>Ul|
||9|0<br> '<br>h|0<br> 0|||||||||||||||||||Cl<br>IO<br>U|
|||U|E|||||||||||||||||||Ql<br>UI|
||||OI<br>0IL<br>CL||IO<br>0<br>IN|W|||||||||N<br>OO <br>m <br>U<br>m|I<br> 0<br> 0<br>IO<br>Ul||Im||QO<br>IO|Ul<br>IO|U0<br>CIS 0<br>CO<br>CI<br>0<br>N<br>0.<br>0<br>IO<br>0<br>OI<br>Ul<br>0 e|
|||||||||||||||||||||||Ul|
|||||||||||||||||||||||Ul<br>0<br>Cl|
||e'2 e<br>C~e8<br>N<br>e a|||0 <br>CI<br>Ol<br>~(|a <br>0<br>N<br>IO<br>IO0<br> IC|w|0<br>QO<br>O<br>OO<br>O I<br>N O<br>Ul|||||QO<br>OO<br>O|CI8|||||||||CE<br>e<br>IO C<br>U0 c<br>tO<br>0<br>IO|
|||||||||||||||||||||||IO|
||||||Ul<br>a0<br>IA|Ul|0 <br>o <br>0 <br>0<br>co|0<br> m<br> 0<br>OO<br> m|||||0<br>Q0|||||||O|000|L<br>Q<br>N00<br>1OC|
||OO0'0|||||||||||||||||||||0!<br>o E<br>0C U|
|||||||||||||||||||||||Cl<br>IO|
||Cl<br>'O0<br>CI<br>100|||I<br>g <br>LI|Cl<br>W<br>UI<br> 0||000<br>O<br>m||||||Cl<br>Ul|||||||||Cl<br>Yl<br>LQ +<br>Cl '0|
||||||||||||||m|||||||||U<br>Cl|
|||||||||||||||||||||||Cl<br>Ul|
|IO<br>c<br>U<br>0<br>Ol<br>QL<br>0|0<br>0<br>Cl||Cl<br>C<br>CI<br>Ul<br>—E3<br>E<br>PJ||||o|m||||||||||||OO00<br>Ul|0<br>tO0,0|IO<br>IO<br>IO<br>Cl<br>Ol0<br>L 0<br>Ol e<br>N<br>0<br>Cl|
|U<br>I||||||||||||||||||||||E<br>Ul<br>E0V<br>X<br>Cl|
|D0X<br>LC<br>CI<br>ITO<br>C<br>IOI-||||||0<br>,0 <br>0 <br>O <br>0<br>U|tl<br> 0<br>OO<br> 0<br> 0<br>Q<br>00 8Q<br>I 0|||8|O<br> E|C||0<br>0<br>OtL00<br>OOlt0|Ol<br>~I<br>0|O8El<br>0|"I<br>E<br>0<br>IL 0<br>C||5<br>00<br>-U <br>0S <br>IO2|M<br>IU<br>I<br> 0<br> M<br>Ul|O<br>0<br>m<br>I|C 11<br>Cl<br>v<br>tO<br>Cl 0<br>OO0<br>'0<br>C<br>ClU<br>Sle<br>CIe<br>N|





## 

## 

## 

## 

||||2022||2021||
|---|---|---|---|---|---|---|
||||Freehold|Long|Freehold|Long|
||||property|leasehold|property|leasehold|
|||||property||property|
||||6|6||6|
|Cost|||16,315,587|168,271|16,264,383|157,483|
|Accumulated|impairment|(losses)/gains|(7,321,022)|41,074|(7,269,818)|51,862|
|Accumulated|depreciation||(2,914,565)|(54,345)|~(2,914,555|(54,345)|
|Net book value|||690809000|155000|6,080,000|155,000|



## 

||||Group||Charity||
|---|---|---|---|---|---|---|
||||2022|2021|2022|2021|
|Listed Investments:|||6|6|6|6|
|Market value at|beginning|ofyear|1,540,386|1,000,970|1,540,386|1,000,970|
|Additions|||2,777,496|1,085,529|2,777,496|1,085,529|
|Disposals|||(467,667)|(653,559)|(467,667)|(653,559)|
|Flet investment|gains / (losses)||64,075|107,446|64,075|107,446|
|Market value at|end ofyear||3,814,290|1,540,386|3,914,290|1,540,386|
|Investment<br>cash|||757,440|1,050,556|757,440|1,050,556|
|Market value at|end ofyear||4.671,730|2,590,942|4,671,730|2,590,942|
|Unlisted<br>investments|||10|10|84|84|
||||4,671,740|2,590,952|4,671,814|2,591,026|
|Historical cost of listed investments|||3,755,427|1,415,427|3,755,427|1,415,427|





## 

## 

## 

|end is more|than 2|0%|as follows:|||||||y|
|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||Class and|
|||||||Country of||||percentage of|
|||||Note||incorporation||Principal activity||shares held|
|Subsidiary|undertaking||||||||||
|St Luke's Options||Limited||22|England|and Wales||Trades for the||100SSordinary|
|||||||||benefit ofSt Luke' s|||
|||||||||Hospice|||
|StLuke's Promotions<br>St Luke's Care Limited|||Limited||England<br>England|and Wales<br>and Wales||Dormant<br>Dormant||10%6ordinary<br>100%ordinary|
|Debtors|||||||||||
|||||||Group|||Charity||
|||||||2022||2021|2022|2021|
|||||||E||6|E|E|
|Trade debtors|||||718,952|||265,571|718,952|258,671|
|Income tax|recoverable||||99,245|||172,431|99,245|172,431|
|Prepayments<br>and <br>Other debtors||accrued income|||2,506,156<br>176,745||1,386,608<br>392,314||2,506,156<br>176p745|1,386,608<br>395,131|
|Amounts<br>owed by||group undertakings|||||||70,610|51,286|
||||||3,501,098||2,216,924||3,571,708|2,264,127|
|Cash and Bank|||||||||||
|||||||Group|||Charity||
|||||||2022||2021|2022|2021|
|||||||f.||6|E|E|
|Cash at bank|||||3,406,872||2,730,200||3,324,369|2,661,483|
|Cash in hand|||||4,647|||4,463|4p647|4,463|
||||||gi411i519||2|734i663|3329416|2,665,946|



## 



## 

## 

## 

## 

## 

||Group||Charity||
|---|---|---|---|---|
||2022<br>f|2021f|2022|2021f|
|Trade creditors<br>Other creditors<br>Taxation and social security<br>Accruals and deferred<br>income (note 13)<br>Amounts<br>owed to group undertakings|496,829<br>165,250<br>135p071<br>2,427,142|645,624<br>145,012<br>109,777<br>1,914,795|496,829<br>165,250<br>135,071<br>2,427,142|645,624<br>145,012<br>109,777<br>1,900,712|
||3,224,292|2,815,208|3,224+92|2,801,125|
|Creditors: amounts<br>falling due after more|than one year||||
||||2022|2021|
||||f|f|
|Group and Charity|||||
|Other creditors|||50,387|98,808|
|Deferred income|||||
|Group and Charity|||||
|Balance at 1April 2021<br>Amount<br>released to SOFA<br>Amounts<br>utilised<br>in the year<br>Amount deferred<br>in the year<br>Balance at 31March 2022||||853,228<br>(5,258)<br>(704,436)<br>1,379,221<br>1,522.755|



||2022|2022|2021|2021|
|---|---|---|---|---|
||Land and||Land and||
||buildingsf|Plant<br>f|buildings<br>f|Plantf|
|Within one year<br>Two to five years<br>Over five years|174,530<br>310,819|4,507<br>1,850|238,166<br>406,516<br>39,834|5,626<br>1,805|
||485,349|6,357|6&4,516|7,431|





## 

## 

## 

## 

|mmary ofm|ovement<br>in funds|||||
|---|---|---|---|---|---|
|||Unrestricted|Designated|Restricted|Total|
|||fund|fund|fund||
|||E||F.||
|Fund balance at 1April 2021<br>Income||10,008,686<br>12,247,819|1,500,000|1,446,756|11,508,686<br>13,694,575|
|Expenditure<br>Investment|gains|(8,589,477)<br>80,788|(115,914)|(1,388,108)|(10,093,499)<br>80,788|
|Transfers<br>Revaluation|on fixed assets|(357,266)<br>(61,991)|415,914|(58,648)|~61.991I|
|Fund balance at 31 March 2022||13,3289559|1,800,000||15,128,559|
|||Unrestricted|Designated|Restricted|Total|
|||fund|fund|fund||
|||||6||
|Fund balance at 1April 2020<br>Income||7,605,365<br>9,837,212|1,350,000|2,927,117|8,955,365<br>12,764,329|
|Expenditure<br>Investment|losses|(6,834,307)<br>167,805|(23,546)|(2,917,117)|(9,774,970)<br>167,805|
|Transfers||(163,546)|173,546|(10,000)||
|Revaluation<br>on fixed assets<br>Fund balance at 31March 2021||(603,843)<br>10,0089686|1,500,000||(603,843)<br>11~9686|





|||||||||||||||||3 <br>0|N<br> IO<br> 0<br>N|UI|Ol<br>Ol<br>44<br>NUNNION|Ol<br>Ol<br>44<br>NUNNION|Ol<br>Ol<br>44<br>NUNNION|Ol<br>Ol<br>44<br>NUNNION|Ol<br>Ol<br>44<br>NUNNION|Ol<br>Ol<br>44<br>NUNNION|Ol<br>Ol<br>44<br>NUNNION|Ol<br>Ol<br>44<br>NUNNION|4<br>I|IU|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||||||||||WWg<br>Nlria|||||||||Ul|
|||||IO||W|0|||'|'||lh|||Ol||hl|D|||||'|Ut||||
|||||W<br>CI'0|||Ul||m||||Ul<br>N<br>ffl|||0|||D<br>I||Ih||||fh<br>IV<br>4'||||
|||||C<br>IO||||||||||||I|'8||||||||||||
|||||I|||||||||||||||||||||||||
||||||||||||||Cl0<br>DO<br>m||||||||||||O<br>0<br>0<br>O<br>0<br>m|'|'|0<br>0<br>0<br>0<br>0<br>Ifl|
|||||||UI|0000D<br>IU||||||00<br>OON|||||W|OO<br>Ct0<br>CtN||||||0<br>O000<br>N||||
||||||0||||||||||||||||||||||||
|||||IO<br>C||III|Q<br>Cl<br>Ct<br>O0||||||O0<br>O<br>O<br>Ul|||Ol<br>0||W|08<br>Ct<br>Cl4'||||||UU00|||Cl00<br>N|
|||||V||||||||||||0|||||||||||||
|||||IO<br>Ol||||||||||||W8|||||||||||||
|||||IO|||||||||||||||||||||||||
|||||Ih||||||||||||Ih|||||||||||||
|||||C <br>Ol<br>V<br>Ol<br>4I|0<br> 0<br>IO<br>IU|W|OO0||||||Ul<br>Ul<br>m<br>IU|||'0 <br>0 <br>Ol<br>Ol <br>4t|0<br> 0<br>IO0<br> '0<br>UI|W|0000<br>Ul|||||||||00<br>N|
||||D|Ol<br>IL'||||||||||||41<br>IL'|||||||||||||
||||4t||||||||||||||||||||||||||
||||0||||||||||||||||||||||||||
||||000<br>D0<br>4||'00<br>IO<br>4IC|W|DO0|NI <br>N<br>N|Ut<br>Ut|IO<br>mm<br>Ct<br>IU|||IO<br>Ut™<br>Ul||||'Ol0<br>OI<br>4t||Nm<br>D00|Oh<br>fh<br>W <br>fh|IO<br>N<br> Ih|Ul<br>Ul|4<br>O<br>IU||Ol<br>Ifl|||0<br>~t<br>IO|
||I-Z||||||||||||||||Ot0||||||||||||
||||I||||||||||||||||||||||||||
||||Ih||||||||||||||||||||||||||
||I||Ol0||||||||||||||||||||||||||
|atVa<br>IIIOZ<br>I/O<br>04<br>LCD<br>IIll|CI<br>UZ<br>~E<br>Z <br>Z<br>I0<br>I-<br>VI<br>III<br>I0Z|UO<br>IUI<br>OO<br>40<br>UE<br> j<br>0<br>Z<br>04<br>Ig|0<br>40<br>IU<br>E<br>00<br>E<br>40<br>Ih<br>III0<br>Ih|a<br>Iv|||rl0<br>0.<br>IUV<br>IO<br>IO<br>UU<br>Ol|Ol <br>E <br>o <br>0|Ol<br> D<br> c<br> a<br>~I<br>X<br>IU|IO 0<br>fh<br>Ol<br>Ot <br>44 <br>Ol<br>o'c <br>IO<br>o 0 <br>0<br>lh<br>0||D0<br>'0<br>Ol<br> C<br> 0<br>tU<br> 0<br> o<br>Ot<br>c0<br> I-|0<br>0<br>IO<br>44<br>0 <br>0 <br>Ol<br>0 <br>IO|C<br>Oli<br> E<br> 0<br>Ol<br> 0<br>th|IUt40<br>IU<br>0<br>Ut<br>IO<br>V<br>Ol0<br>IO<br>Ol<br>'00<br>IL|IO<br>IU|||N0<br>fh<br>Ul<br>Ol<br>V0<br>fh<br>fh<br>UU<br>hl0|~l <br>0 <br>L|~I<br> L<br> a<br> x<br>Ul|IU<br>4!<br>hl<br>tUX<br>00 <br>00 <br>0<br>ol <br>IO <br>IU0|h<br>Ol<br> 8<br> c<br>IU<br> E<br> 0|C '0<br>5<br>0<br>VDD<br>Ot<br>VC fl0<br>44 5<br>E 0<br>ol<br>C<br>OtD E<br>0 0<br>Ol<br>Ol<br>0 0 0<br>I<br>hl|||0 <br>Ol<br>0. <br>E <br>0 <br>V<br>0'0<br>0 <br>E<br>0 <br>D<br>IO<br>0|N<br>IV<br> O<br> N<br> 0<br>IO<br>Ul<br> 0<br>4I<br> 0<br>IO<br>OI<br>C<br>IL|





|||||O <br>I-|fl<br> 0||N<br>Ifl<br>In<br>Ol|IV<br>ffl<br>Itl|Ill|00<br>af<br>m<br>mQ|Ul<br>O<br>O|||Ia<br>CI<br>O||0 <br>Z<br>0|m<br>IU<br> 0<br>IU||00<br>I<br>IU<br>Ul|ah<br>ao<br>Ol|fa<br>Ul <br>(h<br>IU<br>00|m<br> d<br>00<br>Q<br>Io|UtIa<br>00<br>ID|||0 <br>O|Ia|Ol<br>IU<br>O<br>Ul|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||E <br>80|DI<br> Q|W|CtOta<br>Ia<br>ID|||||O8<br>IV<br>ID||||E <br>0 <br>0|Ih<br> h<br> Q|w|Clto<br>IO|||||Cttt<br>Ct<br>UlIa<br>ID|||||
|||||al<br>Ya<br>CI<br>110|||||||||O<br>O<br>O||IaO<br>O|al<br>Ya<br>Q|||||||||0<br>UlI|||taOO|
|||||lo|||||||||||||||||||||||||
|||||||||||||||||I|||||||||||||
||||||||OO<br>OO||||||||OOOOO||||OO0<br>OO|||||||||Ct<br>CIO<br>Ct<br>CI|
|||||||||||||||||0|||||||||||||
|||||||||||||||||I|||||||||||||
||||||||OOO<br>OO||||||||tlOOODd'|||W|O<br>Cttl<br>OO|||||||||O8<br>QO|
|||||||||||||||||01|||||||||||||
|||||V|||||||||||||||||||||||||
|||||00||||||||||||IO|||||||||||||
|||||4I|||||||||||||||||||||||||
|||||ta|||||||||||||||||||||||||
|||||UI||||||||||||UI|||||||||||||
|||||1I <br>C <br>la<br>V<br>IO <br>al|0<br> 0<br>Ia<br> 'll<br>IU|W|O<br>O||ID<br>In<br>mfa||||||O<br>Ia<br>O|'0<br>0 <br>0 <br>al <br>IU|C<br> 0<br> glaV<br> '0<br>OI||0<br>OO||\D<br>Ul<br>fh<br>IU|||||||D<br>CtO|
|||||al<br>IC||||||||||||al<br>IC|||||||||||||
||||11<br>alc<br>00IJ||'0<br>la<br>lo0<br>laO|W|m<br>M<br>Ul<br>O<br>lo|IU<br>f<br>M<br>00<br>Ol|O|d<br>Q|Ul<br>O<br>O O<br>0OO<br>ID<br>fa<br>I<br>h<br>w<br>Ul||lfl<br>ahI|OO<br>Q|IO<br>40<br>IO<br>0<br>CIO<br>O||'ti<br>C<br>4<br>4I0<br>4IO||O|d<br>al<br>ai|fo<br>Q<br>00<br>IO|m<br>0<br>h<br>D<br>IO|N<br>O <br>Io <br>ID|O<br> O<br> Q<br>ID|Od<br>Ul<br>Iae<br>I|O<br>m||rl<br>O<br>CI|
||||Ul0C||||||||||||||||||||||||||
||IZ||100<br>IJ||||||||||||||||||||||||||
||||0||||||||||||||||||||||||||
||||OI||||||||||||||||||||||||||
|U<br>K<br>I/l0X<br>Vl<br>IV<br>1C|IJ<br>Z<br>~E<br>Z<br>lal<br>Z<br>I0<br>I-<br>VI<br>IU|CO<br>tdto<br>Iat<br>Z<br>v<br>10<br>4E<br>Iol<br>CI<br>Z<br>UJ<br>Ig|C0<br>C<br>4C<br>OI<br>E<br>00<br>E<br>4-0<br>IOc|Ia|||CI<br>IU<br>foO<br>O.I<br>fa<br>at<br>0<br>c<br>IL|fo<br>0|4l<br>0<br> a.<br>0|al<br>8<br>'0<br>5<br>U<br>0<br>0 <br>0<br>0 <br>O<br>Ia|E<br>00<br>'tl<br>~I<br> c<br>00 <br> 0IJ<br>al<br>0|110<br>'C<br>4l<br>0<br> 0<br>fa|0<br>7I0<br>0<br>00<br>0<br>0 <br>L<br>fa|tlC<br>10<br>C<br>~I<br>E<br> 0<br>L<br>fa|IUO<br>m<br>Valc<br>la<br>'tl0|'0<br>al<br>IJ|||01<br>ID<br>IU<br>0.<br>al<br>atIJ0Ia<br>ta|E0<br>U0|0 <br>0<br>al<br>0<br>IU|al<br>N<br>'O<br>al<br>U<br>LC00<br> 00<br>la<br>la<br>Dla<br> O|C<br>0<br>aa<br>8<br>0<br>Oft<br>0<br>~I<br>al<br>0|tl<br>at<br>J<br>at<br>0<br>O<br>at<br>C<br>Ia|0 <br>0<br>W<br>4<br>0<br>0<br>0<br>la|10C<br> 1!<br>at<br>E<br>0<br>tU<br>0<br>UI|CIa <br>Ia <br>E <br>0 <br>V<br>E<br>0 <br>5|Io<br> O<br> Io<br> 0<br>V<br>la<br>m<br>0<br>at<br>U00<br>fa<br> 0|
|Vl|||||||||||||||||||||||||||||





## 

## 

## 



## 

## 

## 

|6.<br>Analysis ofmovement<br>in rest|ricted<br>funds|||||
|---|---|---|---|---|---|
|Group and Charity|NHSE|Support|HEYH Deanery||Total|
||funding|a Nurse|funding|Other|2022|
||||6|6|6|
|Fund balance at 1April 2021||||||
|Income|1,191,010|2,484|189,364|63,898|1,446,756|
|Expenditure|(1,191,010)|(2,484)|(189,364)|(5,250)|(1,388,108)|
|Transfers||||(58,648)|(58,648)|
|Fund balance at 31March 2022||||||
|Group and Charity|NHSE|Support a|HEYH||Total|
||funding|Nurse|Deanery|Other|2021|
||||funding|||
||||6|||
|Fund balance at 1April 2020||||||
|Income|2,708,683|8,187|187,747|22,500|2,927,117|
|Expenditure|(2,708,683)|(8,187)|(187,747)|(12,500)|(2,917,117)|
|Transfers||||(10,000)|(10,000)|
|Fund balance at 31March 2021||||||



## 

## 



## 

## 

## 

## 

## 

|Luke's has received f<br>marised<br>as follows:|undi|ng<br>from oth|er bodies (in|cluding<br>Ch|aritable<br>Trust|s) in the financial|year, which is|
|---|---|---|---|---|---|---|---|
||||||||Received in year|
||||||||2022|
||||||||f|
|Funding for capital assets|||||||58,648|
|Funding for revenue|expenditure||||||5,250|
||||||||63,898|
|conciliation ofnet income to net cash flow from||||operating|activities|||
|||||||2022|2021|
||||||||f|
|Net income for the year||||||3,601,076|2,989,359|
|Return on investments||||||(49,503)|(27,271)|
|Depreciation<br>charge||||||115,286|134,289|
|Loss/(profit)<br>on disposal||of fixed assets||||1,286|(3,000)|
|Decrease/(increase)|in stocks|||||84,645|(78,756)|
|(Increase)<br>in debtors||||||(1,284,174)|(395,662)|
|Increase<br>in creditors||||||360p662|561,974|
|Net cash flow provided||by operating|activities|||2,829,278|3,180,933|
|alysis ofcash and cash equivalents||||||||
||||||At|Cashflow|At end of|
|||||beginning of|||year|
||||||year<br>f|f|f|
|Cash at bank and in|hand|||2,734,663||676,856|3,411,519|
|Cash held as investments||||1,050456||(293,116)|757,440|
|||||3,785,219||383,740|4,168,959|



## 



## 

## 

## 


## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 


## 

## 

|Forthe year ende|d 31|March 2022|||
|---|---|---|---|---|
||||2022<br>f|2021f|
|Income|||13,633,879|12,725,012|
|Expenditure|||(10,044,692)|(9,743,080)|
|Net Income|||3,589,187|2,981,932|
|Other recognised|gains||80,788|167,805|
|Net income|||3,669,975|3,149,737|
|Impairment<br>offixed assets|||(61,991)|(603,843)|
|Net movement<br>in|funds||3,607,984|2,545,894|
|Total funds brought forward|||11,501,329|8,952,787|
|Gift aid from subsidiary||company|7,427|2,648|
|Surplus for the financial||year|3,607,984|2,545,894|
|Total funds carried|forward||15,116'740|11,501,329|
|Represented<br>by:|||||
|Unrestricted<br>funds|||15,116,740|11,501,329|
|Restricted funds|||||
||||15,116,740|11,501,329|



